{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:24:28Z","timestamp":1777037068538,"version":"3.51.4"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973898 81774354"],"award-info":[{"award-number":["81973898 81774354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background and Aims:<\/jats:bold> The rapid development of society has resulted in great competitive pressures, leading to the increase in suicide rates as well as incidence and recurrence of depression in recent years. Proprietary Chinese medicines containing <jats:italic>Bupleurum chinense<\/jats:italic> DC. (Chaihu) are widely used in clinical practice. This study aimed at evaluating the efficacy and safety of oral proprietary Chinese medicines containing Chaihu for treating depression by network meta-analysis (NMA) and exploring the potential pharmacological mechanisms of the optimal drugs obtained based on NMA.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This study searched for clinical randomized controlled trial studies (RCTs) about Chaihu-containing products alone or in combination with selective serotonin reuptake inhibitors (SSRI), serotonin-norepinephrine reuptake inhibitors (SNRI), and cyclic antidepressants (CAS) for depression in eight databases. The search deadline is from data inception to April 2021. For efficacy assessment, the clinical response rate, the Hamilton Depression Scale-17 (HAMD-17), and adverse reactions were calculated. The methodological quality of the included studies was assessed for risk of bias following the <jats:italic>Cochrane Handbook for Systematic Reviews<\/jats:italic> of <jats:italic>Interventions<\/jats:italic>, and the data were subjected to NMA via the Stata version 16.0 software. Subsequently, the optimal drug obtained from the NMA results, Danzhi Xiaoyao pill (DZXY), was used to conduct network pharmacology analysis. We searched databases to acquire bioactive and potential targets of DZXY and depression-related targets. The protein-protein interaction (PPI) network, component-target network, the Gene Ontology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed by the STRING database, Cytoscape 3.9.0 software, and R version 4.1.2, respectively.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Thirty-seven RCTs, with a total of 3,263 patients, involving seven oral proprietary Chinese medicines containing Chaihu, were finally included. The results of the NMA demonstrated that the top four interventions with the best efficiency were Jiawei Xiaoyao + SSRI, DZXY + SNRI, Xiaoyao pill + SSRI, and Jieyu pill + SNRI; the top four interventions reducing HAMD score were DZXY + SNRI, Jiawei Xiaoyao, Jieyu pill, and Puyu pill + SNRI; the top four interventions with the least adverse effects were Jieyu pill, Anle pill + SSRI, DZXY + SNRI, and Puyu pill + SNRI. In the aspects above, DZXY + SNRI performed better than other treatments. After network meta-analysis, we conducted a network pharmacology-based strategy on the optimal drugs, DZXY, to provide the pharmacological basis for a conclusion. A total of 147 active compounds and 248 targets in DZXY were identified, of which 175 overlapping targets related to depression. Bioinformatics analysis revealed that MAPK3, JUN, MAPK14, MYC, MAPK1, etc. could become potential therapeutic targets. The MAPK signaling pathway might play an essential role in DZXY against depression.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This is the very first systematic review and network meta-analysis evaluating different oral proprietary Chinese medicines containing Chaihu in depressive disorder. This study suggested that the combination of proprietary Chinese medicines containing Chaihu with antidepressants was generally better than antidepressant treatment. The incidence of adverse reactions with antidepressants alone was higher than that with proprietary Chinese medicines containing Chaihu alone or in combination with antidepressants. DZXY + SNRI showed significantly better results in efficacy, HAMD scores, and safety. The antidepressant effect of DZXY may be related to its regulation of neuroinflammation and apoptosis.<\/jats:p>","DOI":"10.3389\/fphar.2022.773537","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T06:25:58Z","timestamp":1649226358000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Proprietary Medicines Containing Bupleurum chinense DC. (Chaihu) for Depression: Network Meta-Analysis and Network Pharmacology Prediction"],"prefix":"10.3389","volume":"13","author":[{"given":"Qiao-feng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-tian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.27","article-title":"Searching Online Mendelian Inheritance in Man (OMIM): a Knowledgebase of Human Genes and Genetic Phenotypes","volume":"58","author":"Amberger","year":"2017","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"B2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"B3","first-page":"158","article-title":"Curative Effect of Jieyu Pill Combined with Duloxetine on Depression and Their Influences on Serum Neurotransmitters and Related Factors of Nerve Function","volume":"29","author":"Bai","year":"2020","journal-title":"Chin. J. Pharmacoepidemiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/wps.20248","article-title":"The Responsiveness of the Different Versions of the Hamilton Depression Scale","volume":"14","author":"Bech","year":"2015","journal-title":"World Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.13288\/j.11-2166\/r.2020.08.013","article-title":"Study on the Mechanism of Anti-depression Effect of Chaihu(Radix Bupleuri)-Baishao(Radix Paeoniae Alba) Drug Pair Based on Network Pharmacology","volume":"61","author":"Chang","year":"2020","journal-title":"J. Traditional Chin. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.16438\/j.0513-4870.2019-0731","article-title":"The Mechanism of the Anti-depression Effect of the Radix Bupleuri Radix Paeoniae Alba Herb Pair Determined by Liver Metabolomics","volume":"55","author":"Chen","year":"2020","journal-title":"Acta Pharmaceutica Sinica"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e15939","DOI":"10.1371\/journal.pone.0015939","article-title":"TCM Database@Taiwan: the World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico","volume":"6","author":"Chen","year":"2011","journal-title":"PloS one"},{"key":"B8","volume-title":"Clinical Observation of Jiawei Xiaoyao Capsule in Treating 62 Cases of Mild and Moderate Depression with Qi Yu and Fire Syndrome","author":"Chen","year":"2014"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3969\/j.issn.1002-2619.2015.01.005","article-title":"Dominant Complementation Effects of Multi-Model Ensemble on the Treatment of Depression","volume":"37","author":"Chen","year":"2015","journal-title":"Hebei J. Traditional Chin. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3969\/j.issn.1006-1959.2015.13.260","article-title":"Clinical Analysis of Shumian Capsule Combined with Sertraline in the Treatment of Depression","volume":"13","author":"Chen","year":"2015","journal-title":"Med. Inf."},{"key":"B11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.14163\/j.cnki.11-5547\/r.2012.15.201","article-title":"Clinical Analysis of Shumian Capsule Combined with Paroxetine in the Treatment of Depression","volume":"7","author":"Cheng Q","year":"2012","journal-title":"China Pract. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3969\/j.issn.1002-266X.2012.04.023","article-title":"Clinical Observation of 40 Cases of Adolescent Depression Treated with Chinese and Western Medicine","volume":"52","author":"Cheng S","year":"2012","journal-title":"Shandong Med. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.13193\/j.issn.1673-7717.2021.04.007","article-title":"Research Progress on Pharmacology of Saikosaponina","volume":"39","author":"Cheng","year":"2021","journal-title":"Chin. Arch. Traditional Chin. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.13457\/j.cnki.jncm.2016.09.089","article-title":"Clinical Study of Integrated Traditional Chinese and Western Medicine Combined with Nursing Intervention in Depression","volume":"48","author":"Chi","year":"2016","journal-title":"J. New Chin. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-s4-s11","article-title":"cytoHubba: Identifying Hub Objects and Sub-networks from Complex Interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults with Major Depressive Disorder: a Systematic Review and Network Meta-Analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3969\/j.issn.1672-187X.2006.06.014","article-title":"Controlled Study of Venlafaxine Combined with Puyu Capsule in Refractory Depression","volume":"6","author":"Du","year":"2006","journal-title":"J. Clin. Psychosomatic Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.13728\/j.1673-6427.2013.05.027","article-title":"Observation on the Curative Effect of Different Chinese Herbal Compound Combined with Venlafaxine in the Treatment of Depression","volume":"27","author":"Duan","year":"2013","journal-title":"Res. Pract. Chin. Medicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1073\/pnas.1914655117","article-title":"Molecular Adaptations of the Blood-Brain Barrier Promote Stress Resilience vs. Depression","volume":"117","author":"Dudek","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.3390\/ijms21165624","article-title":"Involvement of P38 MAPK in Synaptic Function and Dysfunction","volume":"21","author":"Falcicchia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"554613","DOI":"10.3389\/fncel.2020.554613","article-title":"N-acetylcysteine Rescues Hippocampal Oxidative Stress-Induced Neuronal Injury via Suppression of P38\/JNK Signaling in Depressed Rats","volume":"14","author":"Fan","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1038\/s41467-018-06809-7","article-title":"Mesopontine Cholinergic Inputs to Midbrain Dopamine Neurons Drive Stress-Induced Depressive-like Behaviors","volume":"9","author":"Fernandez","year":"2018","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","article-title":"Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global burden of Disease Study 2010","volume":"10","author":"Ferrari","year":"","journal-title":"PLoS Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1017\/S0033291712001511","article-title":"Global Variation in the Prevalence and Incidence of Major Depressive Disorder: a Systematic Review of the Epidemiological Literature","volume":"43","author":"Ferrari","year":"","journal-title":"Psychol. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1001\/jama.2017.3826","article-title":"Depression Is the Leading Cause of Disability Around the World","volume":"317","author":"Friedrich","year":"2017","journal-title":"Jama"},{"key":"B26","first-page":"3991","article-title":"Current Situation Research and Thinking of Anti-depression with Bupleurum Analogous Decoctions","volume":"33","author":"Gao","year":"2018","journal-title":"China J. Traditional Chin. Med. Pharm."},{"key":"B27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3969\/j.issn.1672-2779.2013.13.027","article-title":"40 Cases of Depression Treated by Xiaoyao Pill Combined with Sertraline","volume":"11","author":"Gao","year":"2013","journal-title":"Chin. Med. Mod. Distance Education China"},{"key":"B28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.7661\/j.cjim.20191222.421","article-title":"Experts\u2019 Consensus on Diagnosis and Treatment of Depression by Integrated Traditional Chinese and Western Medicine","volume":"40","author":"Guo","year":"2020","journal-title":"Chin. J. Integrated Traditional West. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s00018-008-8170-7","article-title":"The Complexity of Mitogen-Activated Protein Kinases (MAPKs) Made Simple","volume":"65","author":"Krishna","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12888-018-1850-4","article-title":"Genotype-dependent Associations between Serotonin Transporter Gene (SLC6A4) DNA Methylation and Late-Life Depression","volume":"18","author":"Lam","year":"2018","journal-title":"BMC Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3969\/j.issn.1007-3256.2008.02.02110.1159\/000114528","article-title":"Clinical Observation of Imipramine Combined with Xiaoyao Pill in the Treatment of Depression","volume":"21","author":"Li","year":"2008","journal-title":"Sichuan Ment. Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3969\/j.issn.1671-2560.2012.10.037","article-title":"Comparative Observation of Jieyu Pill Combined with Paroxetine in the Synergistic Treatment of Depression","volume":"12","author":"Li","year":"2012","journal-title":"Chin. Remedies Clin."},{"key":"B33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1875-5364(19)30048-2","article-title":"The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Atherosclerosis","volume":"17","author":"Li","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.13194\/j.jlunivtcm.2008.03.82.lix.091","article-title":"Clinical Study of Jieyu Pill and Maprotiline in the Treatment of Senile Depression","volume":"3","author":"Li","year":"2008","journal-title":"J. Liaoning Univ. Traditional Chin. Med."},{"key":"B35","volume-title":"Clinical Study on the Effect of Paroxetine Combined with Xiaoyao Pill on Patients with First-Episode Depression","author":"Liu","year":"2017"},{"key":"B36","doi-asserted-by":"publisher","first-page":"867","DOI":"10.7501\/j.issn.1674-5515.2019.03.063","article-title":"Research Progress on Antidepressant Mechanism of Saikosaponina","volume":"34","author":"Liu","year":"2019","journal-title":"Drugs & Clinic."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep21146","article-title":"BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine","volume":"6","author":"Liu","year":"2016","journal-title":"Scientific Rep."},{"key":"B38","first-page":"84+89","article-title":"Effect of Modified Xiaoyao Pill Combined with Escitalopram Oxalate in the Treatment of Depression","volume":"1","author":"Lu","year":"2015","journal-title":"World Latest Med. Inf."},{"key":"B39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3969\/j.issn.1671-1246.2007.01.095","article-title":"Control Study of Xiaoyao Pill Combined with Citalopram in the Treatment of Depression","volume":"1","author":"Ma","year":"2007","journal-title":"Health Vocational Education"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/s41380-019-0548-4","article-title":"Antidepressant Efficacy of a Selective Organic Cation Transporter Blocker in a Mouse Model of Depression","volume":"25","author":"Orrico-Sanchez","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.3969\/j.issn.1008-0805.2013.08.067","article-title":"Clinical Efficacy and Safety Analysis of Jieyu Pill Combined with Citalopram Hydrobromide Tablets in the Treatment of Senile Depression","volume":"24","author":"Pan","year":"2013","journal-title":"Lishizhen Med. Materia Med. Res."},{"key":"B42","volume-title":"The Chinese Classification and the Diagnose Criterion of Mental Disorder (CCMD-3) (In Chinese)","author":"Psychosis Branch of Chinese Medical Association","year":"2001"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a Database of Systems Pharmacology for Drug Discovery from Herbal Medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. cheminformatics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3969\/j.issn.1000-7369.2008.11.041","article-title":"68 Cases of Mild and Moderate Depression Treated with Jieyu Pill","volume":"11","author":"Shi","year":"2008","journal-title":"Shaanxi J. Traditional Chin. Med."},{"key":"B45","first-page":"1432","article-title":"Clinical Observation of Anle Tablet Combined with Paroxetine Hydrochloride in the Treatment of Depression","volume":"26","author":"Shi","year":"2015","journal-title":"Lishizhen Med. Materia Med. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards Suite: from Gene Data Mining to Disease Genome Sequence Analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"410","DOI":"10.19852\/j.cnki.jtcm.2019.03.014","article-title":"Jiawei Xiaoyao Capsule Treatment for Mild to Moderate Major Depression with Anxiety Symptoms: a Randomized, Double-Blind, Double-Dummy, Controlled, Multicenter, Parallel-Treatment Trial","volume":"1","author":"Su","year":"2019","journal-title":"J. Traditional Chin. Med."},{"key":"B48","first-page":"3250","article-title":"Correlative Study on TCM Syndromes and Symptom Checklist 90 Related Psychological Factors in Depression Patients","volume":"7","author":"Sun","year":"2017","journal-title":"China J. Traditional Chin. Med. Pharm."},{"key":"B49","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING V11: Protein\u2013Protein Association Networks with Increased Coverage, Supporting Functional Discovery in Genome-wide Experimental Datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3321\/j.issn:1673-8225.2006.39.001","article-title":"Jieyu Pill versus Venlafaxine Extended Release in the Treatment of Depression at Different Levels of Severity","volume":"39","author":"Tao","year":"2006","journal-title":"Chin. J. Clin. Rehabil."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1021\/mp300198d","article-title":"Drug-likeness Analysis of Traditional Chinese Medicines: Prediction of Drug-Likeness Using Machine Learning Approaches","volume":"9","author":"Tian","year":"2012","journal-title":"Mol. Pharmaceutics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.6039\/j.issn.1001-0408.2015.19.43","article-title":"Advances in Pharmacology and Toxicology of Gardenoside","volume":"26","author":"Wang","year":"2015","journal-title":"China Pharm."},{"key":"B53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.14148\/j.issn.1672-0482.2016.0093","article-title":"The Research Progress in TCM Treatment of Major Depression","volume":"32","author":"Wang","year":"2016","journal-title":"J. Nanjing Univ. Traditional Chin. Med."},{"key":"B54","first-page":"911","article-title":"Study of Jieyu Wan Combined with Fluoxetine in the Treament of Major Depression Disorders. Wang Xinfa, Liu Lu, Han Xiaoyan","volume":"18","author":"Wang","year":"2010","journal-title":"China J. Health Psychol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3969\/j.issn.1672-0369.2014.06.004","article-title":"Comparison of Efficacy and Safety between Jieyu Pills and Venlafaxine in Treatment of Depression","volume":"26","author":"Wang","year":"2014","journal-title":"Med. J. Chin. People's Health"},{"key":"B56","doi-asserted-by":"publisher","first-page":"D1031","DOI":"10.1093\/nar\/gkz981","article-title":"Therapeutic Target Database 2020: Enriched Resource for Facilitating Research and Early Development of Targeted Therapeutics","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5. 0: a Major Update to the DrugBank Database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B58","volume-title":"Depression and Other Common Mental Disorders: Global Health Estimates","year":"2017"},{"key":"B59","volume-title":"ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization","year":"1992"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.7501\/j.issn.0253-2670.2019.04.031","article-title":"Paeonol Derivatives and Their Pharmacological Activities","volume":"4","author":"Wu G","year":"2019","journal-title":"Chin. Traditional Herbal Drugs"},{"key":"B61","first-page":"633","article-title":"Microbiological Regulation Mechanism of Jiawei Xiaoyao Granule in Treating Depression Syndrome of Liver Stagnation and Spleen Deficiency","volume":"30","author":"Wu Y","year":"2019","journal-title":"Lishizhen Med. Materia Med. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"D976","DOI":"10.1093\/nar\/gky987","article-title":"ETCM: an Encyclopaedia of Traditional Chinese Medicine","volume":"47","author":"Xu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3969\/j.issn.1673-7555.2007.24.012","article-title":"Controlled Study on Efficacy Jieyu Pill and Venlafaxine in Treating the First Onset Depression","volume":"24","author":"Xu","year":"2007","journal-title":"China Pract. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.16040\/j.cnki.cn15-1101.2014.04.079","article-title":"Clinical Experience of Treating Senile Depression with Integrated Traditional Chinese and Western Medicine","volume":"33","author":"Xu","year":"2014","journal-title":"Inner Mongolia J. Traditional Chin. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3736\/jcim20120702","article-title":"Therapeutic Effect of Jieyu Pill on Depression","volume":"10","author":"Xu","year":"2012","journal-title":"J. Community Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-319-17656-7_6","article-title":"Clinical Study of Jieyu Pill on Depression","volume":"23","author":"Yang","year":"2015","journal-title":"J. China's Naturopathy."},{"key":"B67","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3969\/j.issn.1001-6910.2012.04.012","article-title":"Treatment of 30 Cases of Senile Depression with Jieyu Pill Combined with Citalopram Hydrobromide Tablets","volume":"25","author":"Yang","year":"2012","journal-title":"Traditional Chin. Med. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3321\/j.issn:1003-5370.2007.07.022","article-title":"Comparative Study of Modified Xiaoyao Pill Combining Amitriptyline on Therapeutic Effect and Compliance in Treating Patients with Depression","volume":"7","author":"Yang","year":"2007","journal-title":"Chin. J. Integrated Traditional West. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3969\/j.issn.1673-0070.2008.03.005","article-title":"Efficacy and Safety of Venlafaxine Combined with Anle Tablet in Recurrent Depression","volume":"3","author":"Yu","year":"2008","journal-title":"Pract. Pharm. Clin. Remedies"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2020.9370","article-title":"Paroxetine Combined with Fluorouracil Plays a Therapeutic Role in Mouse Models of Colorectal Cancer with Depression through Inhibiting IL-22 Expression to Regulate the MAPK Signaling Pathway","volume":"20","author":"Zhang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"B71","first-page":"4060","article-title":"Clinical Comparative Study of Paroxetine Combined with Xiaoyao Pill on Depression","volume":"18","author":"Zhang","year":"2009","journal-title":"Mod. J. Integrated Traditional Chin. West. Med."},{"key":"B72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4236\/cm.2015.62008","article-title":"Observation of Clinical Effect of Carefree Pill Combined Sertraline Treatment of Melancholia","volume":"5","author":"Zhang","year":"2015","journal-title":"China Med. Pharm."},{"key":"B73","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3969\/j.issn.1001-814X.2004.03.060","article-title":"Effect of Fluoxetine and Xiaoyao Pill in the Treatment of Depression","volume":"3","author":"Zhang","year":"2004","journal-title":"J. Contemp. Clin. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2019.00123","article-title":"Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B75","first-page":"5184","article-title":"Advances in Estrogen Research in central Nervous System","volume":"36","author":"Zhang","year":"2016","journal-title":"Chin. J. Gerontol."},{"key":"B76","first-page":"83","article-title":"Clinical Effect of Modified Xiaoyao Pill Combined with Paroxetine in the Treatment of Reactive Depression","volume":"31","author":"Zhang","year":"2014","journal-title":"Inf. Traditional Chin. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.4268\/cjcmm20151036","article-title":"Analysis on Medication Regularity of Modern Traditional Chinese Medicines in Treating Melancholia Based on Data Mining Technology","volume":"40","author":"Zhao","year":"2015","journal-title":"China J. Chin. Materia Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3969\/j.issn.1007-3256.2012.02.011","article-title":"Clinical Observation on Treatment of Depressive Disorder by Fluvoxamine Combined with Xiaoyao Pills","volume":"25","author":"Zhou","year":"2012","journal-title":"Sichuan Ment. Health"},{"key":"B79","first-page":"2804","article-title":"Randomized Controlled Trial of Jiawei Xiaoyao Capsule in the Treatment of Mild to Moderate Depression","volume":"28","author":"Zhou","year":"2013","journal-title":"China J. Traditional Chin. Med. Pharm."},{"key":"B80","doi-asserted-by":"publisher","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","article-title":"Therapeutic Target Database Update 2022: Facilitating Drug Discovery with Enriched Comparative Data of Targeted Agents","volume":"50","author":"Zhou","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00702-018-1929-6","article-title":"Epigenetic Signature of MAOA and MAOB Genes in Mental Disorders","volume":"125","author":"Ziegler","year":"2018","journal-title":"J. Neural Transm."},{"key":"B82","doi-asserted-by":"publisher","first-page":"211","DOI":"10.13422\/j.cnki.syfjx.2017100211","article-title":"Medication Regularity of Traditional Chinese Medicine Classical Prescriptions for Depression Based on Apriori and Clustering Algorithm. Chinese Journal of Experimental","volume":"23","author":"Zou","year":"2017","journal-title":"Traditional Med. Formulae"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.773537\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T06:26:52Z","timestamp":1649226412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.773537\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":82,"alternative-id":["10.3389\/fphar.2022.773537"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.773537","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"article-number":"773537"}}